Short-course preoperative radiotherapy increases pelvic fracture risk in rectal cancer

被引:1
|
作者
Vesa, Valiaho [1 ,2 ]
Jaana, Makitalo [1 ,2 ,3 ]
Ia, Kohonen [4 ,5 ]
Anu, Carpelan [2 ,6 ]
Heikki, Minn [1 ,2 ]
Raija, Ristamaki [1 ,2 ]
Annika, Algars [1 ,2 ]
Eetu, Heerva [1 ,2 ]
机构
[1] Turku Univ Hosp, Dept Oncol, Hameentie 11, Turku 20521, Finland
[2] Univ Turku, Kiinamyllynkatu 4-8, Turku 20521, Finland
[3] Turku Univ Hosp, Dept Med Phys, Hameentie 11, Turku 20521, Finland
[4] Univ Turku, Med Res Lab, Tykistokatu 6A, Turku 20520, Finland
[5] Turku Univ Hosp, Med Imaging Ctr Southwest Finland, Hameentie 11, Turku 20521, Finland
[6] Turku Univ Hosp, Dept Digest Surg, Kiinamyllynkatu 4-8, Turku 20521, Finland
关键词
Rectal cancer; Neoadjuvant; Radiotherapy; Chemoradiotherapy; Fracture; TOTAL MESORECTAL EXCISION; RANDOMIZED PHASE-III; RADIATION-THERAPY; INSUFFICIENCY FRACTURES; FOLLOW-UP; CHEMORADIOTHERAPY; CHEMORADIATION; CARCINOMA; TRIAL;
D O I
10.1016/j.ctro.2023.100656
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Pelvic insufficiency fractures (PIFs) are adverse events associated with chemoradiotherapy (CRT) administered preoperatively in rectal cancer, with incidences of 0-33.6% reported in the literature. Data on PIFs after 5 x 5 Gy fractionated short-course radiotherapy (SCRT) using highly conformal radiotherapy techniques such as volumetric modulated arc therapy (VMAT) is limited.Methods: The Turku University Hospital colorectal cancer database was searched for patients operated on for stage I-III rectal cancer during the years 2014-2018. The hospital's routine follow-up includes a 2-year computed tomography (CT) scan, which was systemically re-evaluated to detect PIFs. Only radiotherapy delivered using VMAT and image-guided approaches was included. Baseline demographics, tumor data, and dose-volume data were collected to identify risk factors for PIFs.Results: Median time to CT scan was 24 months. Among the 164 patients analyzed, the 2-year PIF incidence was 22.2% for SCRT (n = 12/54, OR 9.1 (CI95% 1.9-42.9), p = 0.004), 9.1% for CRT (n = 4/44, OR 3.2 (CI95% 0.6-18.3), p = 0.13) and 3.0% (n = 2/66, reference) for those operated on without radiotherapy. The PIF incidence was not explained by differences in dose-volume data in either the SCRT or CRT groups. Fracture risk was higher in women, up to 50% after SCRT. Conclusions: Every fifth patient treated with SCRT and rectal surgery presented with a PIF. Critical bony structures to be avoided during radiotherapy contouring could not be identified. Clinicians, especially those involved with the follow-up of rectal cancer, should be aware of this potentially debilitating and surprisingly common adverse event.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Preoperative short-course radiation therapy with PROtons compared to photons in high-risk RECTal cancer (PRORECT): Initial dosimetric experience
    Pedone, Cristiana
    Sorcini, Bruno
    Staff, Caroline
    Farlin, Johanna
    Fokstuen, Tone
    Frodin, Jan-Erik
    Nilsson, Per J.
    Martling, Anna
    Valdman, Alexander
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2023, 39
  • [32] Relationship between of short-course preoperative radiotherapy and serum albumin level and postoperative complications in rectal cancer surgery
    Trifunovic, Bratislav
    Krsic, Jovan
    Bezmarevic, Mihailo
    Grbovic, Dragan
    Zeljkovic, Dejan
    Neskovic, Branimir
    Soldatovic, Ivan
    Prelevic, Rade
    Mirkovic, Darko
    VOJNOSANITETSKI PREGLED, 2015, 72 (08) : 663 - 669
  • [33] Comparison of treatment results between surgery alone, preoperative short-course radiotherapy, or long-course concurrent chemoradiotherapy in locally advanced rectal cancer
    Yeh, Chung-Hung
    Chen, Miao-Fen
    Lai, Chia-Hsuan
    Huang, Wen-Shih
    Lee, Steve P.
    Chen, Wen-Cheng
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2012, 17 (05) : 482 - 490
  • [34] Compliance and tolerability of short-course radiotherapy followed by preoperative chemotherapy and surgery for high-risk rectal cancer - Results of the international randomized RAPIDO-trial
    van der Valk, Maxime J. M.
    Marijnen, Corrie A. M.
    van Etten, Boudewijn
    Dijkstra, Esmee A.
    Hilling, Denise E.
    Kranenbarg, Elma Meershoek-Klein
    Putter, Hein
    Roodvoets, Annet G. H.
    Bahadoer, Renu R.
    Fokstuen, Tone
    ten Tije, Albert Jan
    Capdevila, Jaume
    Hendriks, Mathijs P.
    Edhemovic, Ibrahim
    Cervantes, Andres M. R.
    de Groot, Derk Jan A.
    Nilsson, Per J.
    Glimelius, Bengt
    van de Velde, Cornelis J. H.
    Hospers, Geke A. P.
    RADIOTHERAPY AND ONCOLOGY, 2020, 147 : 75 - 83
  • [35] Prognostic Significance of Neoadjuvant Rectal Scores in Preoperative Short-Course Radiotherapy and Long-Course Concurrent Chemoradiotherapy for Patients with Locally Advanced Rectal Cancer
    Huang, Wen-Shih
    Kuan, Feng-Che
    Lin, Meng-Hung
    Chen, Miao-Fen
    Chen, Wen-Cheng
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (11) : 4309 - 4318
  • [36] MRI response rate after short-course radiotherapy on rectal cancer in the elderly comorbid patient: results from a retrospective cohort study
    Koeter, T.
    van Elderen, S. G. C.
    van Tilborg, G. F. A. J. B.
    de Wilt, J. H. W.
    Wasowicz, D. K.
    Rozema, T.
    Zimmerman, D. D. E.
    RADIATION ONCOLOGY, 2020, 15 (01)
  • [37] Neoadjuvant short-course hyperfractionated accelerated radiotherapy (SC-HART) combined with S-1 for locally advanced rectal cancer
    Doi, Hiroshi
    Beppu, Naohito
    Odawara, Soichi
    Tanooka, Masao
    Takada, Yasuhiro
    Niwa, Yasue
    Fujiwara, Masayuki
    Kimura, Fumihiko
    Yanagi, Hidenori
    Yamanaka, Naoki
    Kamikonya, Norihiko
    Hirota, Shozo
    JOURNAL OF RADIATION RESEARCH, 2013, 54 (06) : 1118 - 1124
  • [38] Prognostic Value of Pretreatment Carcinoembryonic Antigen (CEA) in Rectal Cancer Treated with Preoperative Short-Course Radiotherapy with Delayed Surgery or Long-Course Radiotherapy
    Lin, Yun-Hsuan
    Hsu, Hsuan-Chih
    Huang, Eng-Yen
    ONCOTARGETS AND THERAPY, 2025, 18 : 73 - 86
  • [39] Benefits and drawbacks of short-course preoperative radiotherapy in rectal cancer patients aged 75 years and older
    Maas, H. A. A. M.
    Lemmens, V. E. P. P.
    Nijhuis, P. H. A.
    de Hingh, I. H. J. T.
    Koning, C. C. E.
    Janssen-Heijnen, M. L. G.
    EJSO, 2013, 39 (10): : 1087 - 1093
  • [40] Preoperative conventional chemoradiotherapy versus short-course radiotherapy with delayed surgery for rectal cancer: results of a randomized controlled trial
    Tadas Latkauskas
    Henrikas Pauzas
    Laura Kairevice
    Aleksandras Petrauskas
    Zilvinas Saladzinskas
    Rasa Janciauskiene
    Jurate Gudaityte
    Paulius Lizdenis
    Saulius Svagzdys
    Algimantas Tamelis
    Dainius Pavalkis
    BMC Cancer, 16